{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:42:00Z","timestamp":1794411720055,"version":"4.9.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH-funded Caribbean, Central and South America network for HIV epidemiology (CCASAnet), a member cohort of the International Epidemiologic Databases to Evaluate AIDS","award":["U01AI069923"],"award-info":[{"award-number":["U01AI069923"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Global mortality from AIDS-related diseases has been declining since 2005, resulting primarily from the widespread use and early initiation of combination antiretroviral therapy. Despite the significant improvements, high rates of early mortality, usually defined as that occurring within the 1st year of entry to care, have been observed, especially in resource-limited settings. This analysis draws upon data from an observational cohort of people with HIV (PWH) followed at a reference center for HIV\/AIDS care and research in the city of Rio de Janeiro, Brazil, to identify the pattern and factors associated with early mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study population includes PWH aged 18 or older followed at the National Institute of Infectious Diseases Evandro Chagas who were enrolled between 2004 and 2015. The primary outcome was early mortality, defined as deaths occurring within 1\u00a0year of inclusion in the cohort, considering two follow-up periods: 0 to 90\u00a0days (very early mortality) and 91 to 365\u00a0days (early mortality). Cox proportional hazards models were used to identify the variables associated with the hazard of very early and early mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 3879 participants contributed with 3616.4 person-years of follow-up. Of 220 deaths, 132 happened in the first 90\u00a0days and 88 between 91 and 365\u00a0days. Very early mortality rate ratios (MRR) show no statistically significant temporal differences between the periods 2004\u20132006 to 2013\u20132015. In contrast, for early mortality, a statistically significant decreasing trend was observed: mortality rates in the periods 2004\u20132006 (MR\u2009=\u20095.5; 95% CI 3.9\u20137.8) and 2007\u20132009 (MR\u2009=\u20093.9; 95% CI 2.7\u20135.7) were approximately four and three-fold higher when compared to 2013\u20132015 (MR\u2009=\u20091.4; 95% CI 0.7\u20132.7). Low CD4 count and prior AIDS-defining illness were strongly associated with higher hazard ratios of death, especially when considering very early mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study shows an excess of mortality in the 1st year of follow-up with no changes in the mortality rates within 90\u00a0days among PWH from Rio de Janeiro. We note the significant impact of initiating treatment with immunosuppression, as evidenced by the increased risk of death among those with low CD4 cell count and with AIDS-defining illnesses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07451-x","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:15:59Z","timestamp":1652789759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004\u20132015: a persisting problem"],"prefix":"10.1186","volume":"22","author":[{"given":"Pedro H. A. C.","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara E.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra W.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"7451_CR1","unstructured":"Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. 1992. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00018871.htm. Accessed 9 Feb 2020."},{"key":"7451_CR2","unstructured":"Brasil. Recomenda\u00e7\u00f5es para Terapia Anti-Retroviral em Adultos e Adolescentes Infectados pelo HIV 2004. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Programa Nacional de DST e Aids; 2004."},{"key":"7451_CR3","volume-title":"Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV: 2008","author":"Programa Nacional de DST e Aids","year":"2008","unstructured":"Programa Nacional de DST e Aids. Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV: 2008. Bras\u00edlia: Programa Nacional de DST e Aids; 2008."},{"key":"7451_CR4","unstructured":"Brasil. Protocolo Cl\u00ednico e Diretrizes Cl\u00ednicas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos. Bras\u00edlia, DF: Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais; 2018."},{"key":"7451_CR5","doi-asserted-by":"publisher","first-page":"e59768","DOI":"10.1371\/journal.pone.0059768","volume":"8","author":"B Grinsztejn","year":"2013","unstructured":"Grinsztejn B, Luz PM, Pacheco AG, Santos DVG, Velasque L, Moreira RI, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART Era. PLoS ONE. 2013;8:e59768.","journal-title":"PLoS ONE"},{"key":"7451_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3851\/IMP2716","volume":"19","author":"SR Ribeiro","year":"2014","unstructured":"Ribeiro SR, Luz PM, Campos DP, Moreira RI, Coelho L, Japiassu A, et al. Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000\u20132010. Antivir Ther (Lond). 2014;19:387\u201397.","journal-title":"Antivir Ther (Lond)"},{"key":"7451_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0956462415624075","volume":"28","author":"SM Raboni","year":"2017","unstructured":"Raboni SM, Ribeiro CE, Almeida SM, Telles JPM, Azevedo M, Schaitza GA. Impact of public health strategies on reducing AIDS mortality in southern Brazil. Int J STD AIDS. 2017;28:54\u201362.","journal-title":"Int J STD AIDS"},{"key":"7451_CR8","first-page":"e00009617","volume":"34","author":"TdA Lima","year":"2018","unstructured":"Lima TdA, Beyrer C, Golub JE, Mota JCd, Malta MS, Silva CMFPd, et al. Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil. Cad Saude Publica. 2018;34:e00009617.","journal-title":"Cad Saude Publica"},{"key":"7451_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1590\/S1020-49892012000800005","volume":"32","author":"SMGd Rossi","year":"2012","unstructured":"Rossi SMGd, Maluf ECP, Carvalho DS, Ribeiro CEL, Battaglin CRP. Impact of antiretroviral therapy under different treatment regimens. Rev Panam Salud Publica. 2012;32:117\u201323.","journal-title":"Rev Panam Salud Publica"},{"key":"7451_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12879-019-3844-3","volume":"19","author":"TD Mangal","year":"2019","unstructured":"Mangal TD, Meireles MV, Pascom ARP, de Almeida CR, Benzaken AS, Hallett TB. Determinants of survival of people living with HIV\/AIDS on antiretroviral therapy in Brazil 2006\u20132015. BMC Infect Dis. 2019;19:206.","journal-title":"BMC Infect Dis"},{"key":"7451_CR11","doi-asserted-by":"publisher","first-page":"20623","DOI":"10.7448\/IAS.19.1.20623","volume":"19","author":"PM Luz","year":"2016","unstructured":"Luz PM, Girouard MP, Grinsztejn B, Freedberg KA, Veloso VG, Losina E, et al. Survival benefits of antiretroviral therapy in Brazil: a model-based analysis. J Int AIDS Soc. 2016;19:20623.","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 4","key":"7451_CR12","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/01.aids.0000279705.24428.a3","volume":"21","author":"DB Greco","year":"2007","unstructured":"Greco DB, Sim\u00e3o M. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives. AIDS. 2007;21(Suppl 4):S37-45.","journal-title":"AIDS"},{"key":"7451_CR13","first-page":"e151","volume":"42","author":"EA Melo","year":"2018","unstructured":"Melo EA, Maksud I, Agostini R. Cuidado, HIV\/Aids e aten\u00e7\u00e3o prim\u00e1ria no Brasil: desafio para a aten\u00e7\u00e3o no Sistema \u00danico de Sa\u00fade? Rev Panam Salud Publica. Organizaci\u00f3n Panamericana de la Salud. 2018;42:e151.","journal-title":"Organizaci\u00f3n Panamericana de la Salud"},{"key":"7451_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897\u2013908.","journal-title":"AIDS"},{"key":"7451_CR15","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1097\/QAD.0b013e32832ec494","volume":"23","author":"B Grinsztejn","year":"2009","unstructured":"Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, Campos DP, et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2009;23:2107\u201314.","journal-title":"AIDS"},{"key":"7451_CR16","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"A Trickey","year":"2017","unstructured":"Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349\u201356.","journal-title":"Lancet HIV"},{"key":"7451_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","volume":"367","author":"P Braitstein","year":"2006","unstructured":"Braitstein P, Brinkhof MWG, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817\u201324.","journal-title":"Lancet"},{"key":"7451_CR18","doi-asserted-by":"publisher","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","volume":"6","author":"A Gupta","year":"2011","unstructured":"Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, et al. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE. 2011;6:e28691.","journal-title":"PLoS ONE"},{"key":"7451_CR19","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/MD.0000000000009857","volume":"97","author":"ARP Pascom","year":"2018","unstructured":"Pascom ARP, Meireles MV, Benzaken AS. Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016. Medicine (Baltimore). 2018;97:S69\u201374.","journal-title":"Medicine (Baltimore)"},{"key":"7451_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/QAD.0b013e32835ad504","volume":"27","author":"LRFS Kerr","year":"2013","unstructured":"Kerr LRFS, Mota RS, Kendall C, Pinho AdA, Mello MB, Guimar\u00e3es MDC, et al. HIV among MSM in a large middle-income country. AIDS. 2013;27:427\u201335.","journal-title":"AIDS"},{"key":"7451_CR21","doi-asserted-by":"publisher","first-page":"e1001418","DOI":"10.1371\/journal.pmed.1001418","volume":"10","author":"LF Johnson","year":"2013","unstructured":"Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013;10:e1001418.","journal-title":"PLoS Med"},{"key":"7451_CR22","doi-asserted-by":"publisher","first-page":"d6016","DOI":"10.1136\/bmj.d6016","volume":"343","author":"M May","year":"2011","unstructured":"May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ. 2011;343:d6016.","journal-title":"BMJ"},{"key":"7451_CR23","unstructured":"Campos D, De C, Vieira Lisboa S, Luiz A, Matzenbacher, Grinsztejn B, et al. Banco de dados de indiv\u00edduos HIV positivos para fins de pesquisa cl\u00ednica: elabora\u00e7\u00e3o e atualiza\u00e7\u00e3o. Florian\u00f3polis; 2006. p. 6."},{"key":"7451_CR24","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/aje\/kwn249","volume":"168","author":"AG Pacheco","year":"2008","unstructured":"Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, et al. Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. Am J Epidemiol. 2008;168:1326\u201332.","journal-title":"Am J Epidemiol"},{"key":"7451_CR25","unstructured":"CDC. AIDS-defining conditions. Atlanta: Centers for Disease Control and Prevention; 2008. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5710a2.htm."},{"key":"7451_CR26","volume-title":"An\u00e1lise de sobreviv\u00eancia aplicada","author":"EA Colosimo","year":"2006","unstructured":"Colosimo EA, Giolo SR. An\u00e1lise de sobreviv\u00eancia aplicada. S\u00e3o Paulo: Edgard Bl\u00fccher; 2006."},{"key":"7451_CR27","unstructured":"Harrell Jr FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Switzerland: Springer; 2010. https:\/\/ebookcentral.proquest.com\/lib\/byu\/detail.action?docID=3085295. Accessed 7 Sept 2019."},{"key":"7451_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/10629360600810434","volume":"76","author":"S Van Buuren","year":"2006","unstructured":"Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB. Fully conditional specification in multivariate imputation. J Stat Comput Simul. 2006;76:1049\u201364.","journal-title":"J Stat Comput Simul"},{"key":"7451_CR29","doi-asserted-by":"publisher","DOI":"10.4135\/9781412985079","volume-title":"Missing data","author":"PD Allison","year":"2002","unstructured":"Allison PD. Missing data. Thousand Oaks: Sage Publications; 2002."},{"key":"7451_CR30","volume-title":"Multiple Imputation of missing data using SAS","author":"P Berglund","year":"2014","unstructured":"Berglund P, Heeringa SG. Multiple Imputation of missing data using SAS. Cary: SAS Institute; 2014."},{"key":"7451_CR31","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021. https:\/\/www.R-project.org\/."},{"key":"7451_CR32","unstructured":"Harrel Jr. FE. Hmisc: Harrell Miscellaneous. R package version 4.5-0. 2021. https:\/\/CRAN.R-project.org\/package=Hmisc. http:\/\/biostat.mc.vanderbilt.edu\/Hmisc. Accessed 5 Jan 2019."},{"key":"7451_CR33","unstructured":"Harrel Jr. FE. rms: Regression Modelling Strategies. R package version 5.1-3.1. 2019. https:\/\/CRAN.R-project.org\/package=rms."},{"key":"7451_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515\u201326.","journal-title":"Biometrika"},{"key":"7451_CR35","unstructured":"Therneau TM. survival: Survival Analysis. R package version 3.2\u201311. 2021. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"7451_CR36","volume-title":"Survival analysis using SAS: a practical guide","author":"PD Allison","year":"2010","unstructured":"Allison PD. Survival analysis using SAS: a practical guide. 2nd ed. Cary: SAS Institute; 2010.","edition":"2"},{"key":"7451_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/hiv.12421","volume":"18","author":"S Teeraananchai","year":"2017","unstructured":"Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18:256\u201366.","journal-title":"HIV Med"},{"key":"7451_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000001112","volume":"73","author":"AT Brennan","year":"2016","unstructured":"Brennan AT, Long L, Useem J, Garrison L, Fox MP. Mortality in the first 3 months on antiretroviral therapy among HIV-positive adults in low- and middle-income countries: a meta-analysis. J Acquir Immune Defic Syndr. 2016;73:1\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7451_CR39","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1097\/QAD.0000000000001606","volume":"31","author":"GP Bisson","year":"2017","unstructured":"Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, et al. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS. 2017;31:2217\u201325.","journal-title":"AIDS"},{"key":"7451_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/aid.2007.0217","volume":"24","author":"MC Marazzi","year":"2008","unstructured":"Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, Ceffa S, et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retrovir. 2008;24:555\u201360.","journal-title":"AIDS Res Hum Retrovir"},{"key":"7451_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/QAI.0b013e3181a44f0a","volume":"51","author":"S Tuboi","year":"2009","unstructured":"Tuboi S, Schechter M, McGowan C, Cesar C, Krolewiecki A, Cahn P, et al. Mortality during the first year of potent antiretroviral therapy in HIV-1-Infected patients in 7 sites throughout Latin America and the Caribbean. JAIDS J Acquir Immune Defic Syndr. 2009;51:615\u201323.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"7451_CR42","doi-asserted-by":"publisher","first-page":"e0198815","DOI":"10.1371\/journal.pone.0198815","volume":"13","author":"HA Gesesew","year":"2018","unstructured":"Gesesew HA, Ward P, Woldemichael K, Mwanri L. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003\u201315. PLoS ONE. 2018;13:e0198815.","journal-title":"PLoS ONE"},{"key":"7451_CR43","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/QAD.0b013e3283611931","volume":"27","author":"L Liao","year":"2013","unstructured":"Liao L, Xing H, Su B, Wang Z, Ruan Y, Wang X, et al. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS. 2013;27:1815\u201324.","journal-title":"AIDS"},{"key":"7451_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2334-8-52","volume":"8","author":"A Johannessen","year":"2008","unstructured":"Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8:52.","journal-title":"BMC Infect Dis"},{"key":"7451_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1037\/a0032694","volume":"68","author":"JA Pellowski","year":"2013","unstructured":"Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68:197\u2013209.","journal-title":"Am Psychol"},{"key":"7451_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s13524-011-0084-6","volume":"49","author":"LJ Marteleto","year":"2012","unstructured":"Marteleto LJ. Educational inequality by race in Brazil, 1982\u20132007: structural changes and shifts in racial classification. Demography. 2012;49:337\u201358.","journal-title":"Demography"},{"key":"7451_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s13524-016-0484-8","volume":"53","author":"L Marteleto","year":"2016","unstructured":"Marteleto L, Dondero M. Racial inequality in education in Brazil: a twins fixed-effects approach. Demography. 2016;53:1185\u2013205.","journal-title":"Demography"},{"key":"7451_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S0102-69092010000200005","volume":"25","author":"PF de Souza","year":"2010","unstructured":"de Souza PF, Ribeiro CAC, Carvalhaes F. Desigualdade de oportunidades no Brasil: considera\u00e7\u00f5es sobre classe, educa\u00e7\u00e3o e ra\u00e7a. Revista Brasileira de Ci\u00eancias Sociais. 2010;25:77\u2013100.","journal-title":"Revista Brasileira de Ci\u00eancias Sociais"},{"key":"7451_CR49","volume-title":"PNAD Cont\u00ednua - Caracter\u00edsticas gerais dos domic\u00edlios e dos moradores 2018","author":"IBGE","year":"2019","unstructured":"IBGE. PNAD Cont\u00ednua - Caracter\u00edsticas gerais dos domic\u00edlios e dos moradores 2018. Bras\u00edlia: IBGE, Coordena\u00e7\u00e3o de Trabalho e Rendimento; 2019."},{"key":"7451_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","volume":"12","author":"A Antinori","year":"2011","unstructured":"Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12:61\u20134.","journal-title":"HIV Med"},{"key":"7451_CR51","doi-asserted-by":"publisher","first-page":"e003320","DOI":"10.1136\/bmjopen-2013-003320","volume":"3","author":"Y Wang","year":"2013","unstructured":"Wang Y, Hunt K, Nazareth I, Freemantle N, Petersen I. Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open. 2013;3:e003320.","journal-title":"BMJ Open"},{"key":"7451_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2989\/16085906.2015.1052526","volume":"14","author":"JO Akinyemi","year":"2015","unstructured":"Akinyemi JO, Adesina OA, Kuti MO, Ogunbosi BO, Irabor AE, Odaibo GN, et al. Temporal distribution of baseline characteristics and association with early mortality among HIV-positive patients at University College Hospital, Ibadan, Nigeria. Afr J AIDS Res. 2015;14:201\u20137.","journal-title":"Afr J AIDS Res"},{"key":"7451_CR53","doi-asserted-by":"publisher","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","volume":"11","author":"A Boulle","year":"2014","unstructured":"Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS Med. 2014;11:e1001718.","journal-title":"PLoS Med"},{"key":"7451_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12879-015-0960-6","volume":"15","author":"B Suligoi","year":"2015","unstructured":"Suligoi B, Zucchetto A, Grande E, Camoni L, Dal Maso L, Frova L, et al. Risk factors for early mortality after AIDS in the cART era: a population-based cohort study in Italy. BMC Infect Dis. 2015;15:229.","journal-title":"BMC Infect Dis"},{"key":"7451_CR55","unstructured":"UNAIDS. 2020 Global AIDS Update\u2060\u2014Seizing the moment\u2060\u2014tackling entrenched inequalities to end epidemics. 2020;384."},{"key":"7451_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12879-015-0837-8","volume":"15","author":"RMSM Domingues","year":"2015","unstructured":"Domingues RMSM, Szwarcwald CL, Souza PRB, Leal MdC. Prenatal testing and prevalence of HIV infection during pregnancy: data from the \u2018Birth in Brazil\u2019 study, a national hospital-based study. BMC Infect Dis. 2015;15:100.","journal-title":"BMC Infect Dis"},{"key":"7451_CR57","unstructured":"Tomasi E, Fernandes PAA, Fischer T, Siqueira FCV, Silveira DS da, Thum\u00e9 E, et al. Quality of prenatal services in primary healthcare in Brazil: indicators and social inequalities. Cadernos de Sa\u00fade P\u00fablica. Escola Nacional de Sa\u00fade P\u00fablica, Funda\u00e7\u00e3o Oswaldo Cruz; 2017;33. http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S0102-311X2017000305001&lng=pt&nrm=iso&tlng=pt. Accessed 3 Apr 2021."},{"key":"7451_CR58","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.1016\/S2352-3018(16)30052-2","volume":"3","author":"L Coelho","year":"2016","unstructured":"Coelho L, Grinsztejn B, Castilho JL, De Boni R, Quintana MSB, Campos DP, et al. Mortality among HIV-infected women, heterosexual men, and men who have sex with men: insights from an observational cohort study. Lancet HIV. 2016;3:e490\u20138.","journal-title":"Lancet HIV"},{"key":"7451_CR59","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jinf.2016.01.017","volume":"72","author":"P Sobrino-Vegas","year":"2016","unstructured":"Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004\u20132013. J Infect. 2016;72:587\u201396.","journal-title":"J Infect"},{"key":"7451_CR60","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/QAD.0000000000002621","volume":"34","author":"ME Santos","year":"2020","unstructured":"Santos ME, Protopopescu C, Ribeiro RA, Benzaken AS, Pereira GFM, Stevens A, et al. Population attributable fractions of mortality in people living with HIV: roles of delayed ART, hepatitis coinfections and social factors. AIDS. 2020;34:1843\u201354.","journal-title":"AIDS"},{"key":"7451_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/QAI.0000000000000247","volume":"67","author":"V Saraceni","year":"2014","unstructured":"Saraceni V, Cohn S, Cavalcante SC, Pacheco AGF, Moulton LH, Chaisson RE, et al. Prevalent tuberculosis (TB) at HIV diagnosis in Rio de Janeiro, Brazil: the TB\/HIV in Rio (THRio) Cohort. J Acquir Immune Defic Syndr. 2014;67:98\u2013101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7451_CR62","doi-asserted-by":"publisher","first-page":"e0207859","DOI":"10.1371\/journal.pone.0207859","volume":"13","author":"V Saraceni","year":"2018","unstructured":"Saraceni V, Benzaken AS, Pereira GFM, Andrade KB, Oliveira PB, Arakaki-Sanchez D, et al. Tuberculosis burden on AIDS in Brazil: a study using linked databases. PLoS ONE. 2018;13:e0207859.","journal-title":"PLoS ONE"},{"key":"7451_CR63","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1590\/1413-81232020255.33672019","volume":"25","author":"WG Mendes","year":"2020","unstructured":"Mendes WG, Silva CMFPd. Homicide of lesbians, gays, bisexuals, travestis, transexuals, and transgender people (LGBT) in Brazil: a spatial analysis. Cien Saude Colet. 2020;25:1709\u201322.","journal-title":"Cien Saude Colet"},{"key":"7451_CR64","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/cix915","volume":"66","author":"IeDEA and COHERE Cohort Collaborations","year":"2018","unstructured":"IeDEA and COHERE Cohort Collaborations. Global trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs. Clin Infect Dis. 2018;66:893\u2013903.","journal-title":"Clin Infect Dis"},{"key":"7451_CR65","doi-asserted-by":"publisher","first-page":"e86305","DOI":"10.1371\/journal.pone.0086305","volume":"9","author":"T Mutasa-Apollo","year":"2014","unstructured":"Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe\u2019s National Antiretroviral Therapy Programme, 2007\u20132010. PLoS ONE. 2014;9:e86305.","journal-title":"PLoS ONE"},{"key":"7451_CR66","first-page":"e2016049","volume":"38","author":"E Tachbele","year":"2016","unstructured":"Tachbele E, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016;38:e2016049.","journal-title":"Epidemiol Health"},{"key":"7451_CR67","doi-asserted-by":"publisher","first-page":"e73181","DOI":"10.1371\/journal.pone.0073181","volume":"8","author":"DA Tran","year":"2013","unstructured":"Tran DA, Ngo AD, Shakeshaft A, Wilson DP, Doran C, Zhang L. Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics. PLoS ONE. 2013;8:e73181.","journal-title":"PLoS ONE"},{"key":"7451_CR68","doi-asserted-by":"publisher","DOI":"10.4135\/9781446268360","volume-title":"Introducing survival and event history analysis","author":"M Mills","year":"2011","unstructured":"Mills M. Introducing survival and event history analysis. 1st ed. Los Angeles: SAGE Publications Ltd; 2011.","edition":"1"},{"key":"7451_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat. 2016;70:129\u201333.","journal-title":"Am Stat"},{"key":"7451_CR70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","volume":"31","author":"S Greenland","year":"2016","unstructured":"Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337\u201350.","journal-title":"Eur J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07451-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:04:11Z","timestamp":1652792651000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07451-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7451"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07451-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of INI\/Fiocruz (CAAE 0032.0.009.000-10) and was conducted according to the principles expressed in the Declaration of Helsinki. All patients signed a free and informed consent term before entering the study and all records\/information were anonymized before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}